BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28705116)

  • 1. Alex3 suppresses non-small cell lung cancer invasion via AKT/Slug/E-cadherin pathway.
    Du J; Zhang X; Zhou H; Miao Y; Han Y; Han Q; Wang E
    Tumour Biol; 2017 Jul; 39(7):1010428317701441. PubMed ID: 28705116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses.
    Chang JH; Cheng CW; Yang YC; Chen WS; Hung WY; Chow JM; Chen PS; Hsiao M; Lee WJ; Chien MH
    J Exp Clin Cancer Res; 2018 Aug; 37(1):199. PubMed ID: 30134935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
    Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
    Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent Akt activation and Snail-independent ADAM9 expression pathways.
    Chang JH; Lai SL; Chen WS; Hung WY; Chow JM; Hsiao M; Lee WJ; Chien MH
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1746-1758. PubMed ID: 28648644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coiled-coil domain-containing protein 8 inhibits the invasiveness and migration of non-small cell lung cancer cells.
    Jiang GY; Zhang XP; Zhang Y; Xu HT; Wang L; Li QC; Wang EH
    Hum Pathol; 2016 Oct; 56():64-73. PubMed ID: 27342910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.
    Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B
    Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma.
    Uchikado Y; Natsugoe S; Okumura H; Setoyama T; Matsumoto M; Ishigami S; Aikou T
    Clin Cancer Res; 2005 Feb; 11(3):1174-80. PubMed ID: 15709186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
    Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
    Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
    Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
    Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion.
    Dang TT; Westcott JM; Maine EA; Kanchwala M; Xing C; Pearson GW
    Oncotarget; 2016 May; 7(19):28592-611. PubMed ID: 27081041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Slug-Mediated Down-Regulation of E-Cadherin on Invasiveness and Metastasis of Anaplastic Thyroid Cancer Cells.
    Sheng L; Zhang S; Xu H
    Med Sci Monit; 2017 Jan; 23():138-143. PubMed ID: 28070118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.
    Shih JY; Tsai MF; Chang TH; Chang YL; Yuan A; Yu CJ; Lin SB; Liou GY; Lee ML; Chen JJ; Hong TM; Yang SC; Su JL; Lee YC; Yang PC
    Clin Cancer Res; 2005 Nov; 11(22):8070-8. PubMed ID: 16299238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-1285-5p influences the proliferation and metastasis of non-small-cell lung carcinoma cells via downregulating CDH1 and Smad4.
    Zhou S; Zhang Z; Zheng P; Zhao W; Han N
    Tumour Biol; 2017 Jun; 39(6):1010428317705513. PubMed ID: 28631567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway.
    Xia J; Yu X; Tang L; Li G; He T
    Oncol Rep; 2015 Jul; 34(1):103-10. PubMed ID: 25976617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
    Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
    Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer.
    Chen Y; Min L; Zhang X; Hu S; Wang B; Liu W; Wang R; Gu X; Shen W; Lv H; Zou J; Chen Y; Xu X; Chen L
    Oncol Rep; 2013 Oct; 30(4):1832-40. PubMed ID: 23843100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.